Pharmacy - Other

07.02.2018  | CMS Responds to Massachusetts Medicaid Waiver Requests
Last week, the Centers for Medicare and Medicaid Services responded to the state’s 1115 Medicaid Waiver request that had been filed last September.
06.18.2018  | Mass. House Releases Major Healthcare Overhaul
The Massachusetts House of Representatives could begin consideration as early as tomorrow on a massive healthcare reform bill.
06.04.2018  | President Signs Right to Try Legislation
President Trump signed into law the Right to Try Act of 2017, which will allow terminally ill patients to try certain investigational drugs.
03.19.2018  | Warren Defends 340B Program at Senate HELP Hearing
Sen. Elizabeth Warren (D-Mass.) defended the 340B drug program and the hospitals and health centers that rely on it at a hearing last Thursday.
01.08.2018  | Federal Court Dismisses Lawsuit Challenging 340B Cuts
A U.S. District Court dismissed a lawsuit regarding a Medicare policy that would reduce hospital payments under the 340B program.
11.13.2017  | Hospitals Could Get Walloped by 340B Drug Reimbursement Cut
When CMS issued the final outpatient prospective payment system rule last week it etched into regulation what had only been proposed: significant Medicare reimbursement cuts to hospitals for pharmaceuticals.
11.13.2017  | Hospitals Could Get Walloped by 340B Drug Reimbursement Cut
When CMS issued the final outpatient prospective payment system rule last week it etched into regulation what had only been proposed: significant Medicare reimbursement cuts to hospitals for pharmaceuticals.
09.11.2017  | A Call for Stability on Cost-Sharing Reductions
Governor Charlie Baker testified before the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) on Thursday, arguing in favor of continuing the cost-sharing reductions that are included in the Affordable Care Act and that help insur
07.31.2017  | Bad News Regarding Opioids in Mass.
At its Wednesday meeting, the Health Policy Commission (HPC) released data confirming what providers see each day from the opioid crisis in Massachusetts.
07.17.2017  | Groups Call for a Closer Focus on Pharmaceuticals
A broad coalition of organizations, including MHA, called for passage of legislation to promote transparency in prescription drug prices.
07.11.2017  | An Act to Promote Transparency in Prescription Drug Price
MHA appreciates the opportunity to submit comments in strong support of SB627, “An Act to Promote Transparency in Prescription Drug Prices.

Resources

Click on the links below for easy access to important information related to state healthcare issues and advocacy.
Visit the Commonwealth of Massachusetts websites below to find information on legislative hearings and other meetings of interest to the healthcare community.
To guide your navigation of the legislative process and assist your advocacy efforts, please visit the following state websites:
MHA has also developed the following documents for your information and benefit: